ArticleFuture oncology (London, England)2025
CDK4/6 inhibitor plus endocrine therapy for advanced breast cancer: results from a web-based survey in Japan.
Takahiro Nakayama et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
1 paper cites it
this papercites it